EdgarLookup

AGIOS PHARMACEUTICALS, INC. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 144 3 3/A 4 4/A 424B4 424B5 5 8-A12B 8-K ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DEFM14A DRS EFFECT FWP POSASR PREM14A REGDEX S-1 S-1/A S-1MEF S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-14-133697 Apr 7, 2014 May 30, 2014
8-K FORM 8-K 0001193125-14-132503 Apr 7, 2014 Apr 6, 2014
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001193125-14-133740 Apr 7, 2014
4 FORM 4 SUBMISSION 0001209191-14-025627 Apr 3, 2014 Apr 1, 2014
4 FORM 4 SUBMISSION 0001209191-14-025621 Apr 3, 2014 Apr 1, 2014
4 FORM 4 SUBMISSION 0001209191-14-025619 Apr 3, 2014 Jul 24, 2013
4 FORM 4 SUBMISSION 0001209191-14-025617 Apr 3, 2014 Jul 24, 2013
4 FORM 4 SUBMISSION 0001209191-14-025630 Apr 3, 2014 Apr 1, 2014
4 FORM 4 SUBMISSION 0001209191-14-023544 Mar 27, 2014 Mar 25, 2014
4 FORM 4 SUBMISSION 0001209191-14-022273 Mar 20, 2014 Mar 19, 2014
10-K FORM 10-K 0001193125-14-104521 Mar 18, 2014 Dec 31, 2013
4 FORM 4 SUBMISSION 0001209191-14-019975 Mar 12, 2014 Mar 10, 2014
4 FORM 4 SUBMISSION 0001209191-14-019979 Mar 12, 2014 Mar 10, 2014
4 FORM 4 SUBMISSION 0001209191-14-018461 Mar 7, 2014 Mar 5, 2014
4 FORM 4 SUBMISSION 0001209191-14-018496 Mar 7, 2014 Mar 5, 2014
4 FORM 4 SUBMISSION 0001209191-14-018505 Mar 7, 2014 Mar 5, 2014
4 FORM 4 SUBMISSION 0001209191-14-018464 Mar 7, 2014 Mar 5, 2014
8-K FORM 8-K 0001193125-14-085644 Mar 6, 2014
4 FORM 4 SUBMISSION 0001209191-14-016819 Mar 4, 2014 Mar 3, 2014
4 FORM 4 SUBMISSION 0001209191-14-016811 Mar 4, 2014 Mar 3, 2014
4 FORM 4 SUBMISSION 0001209191-14-012651 Feb 20, 2014 Feb 18, 2014
4 FORM 4 SUBMISSION 0001209191-14-012589 Feb 20, 2014 Feb 18, 2014
SC 13G AGIOS PHARMACEUTICALS 0001072613-14-000065 Feb 12, 2014
4 FORM 4 SUBMISSION 0001209191-14-009242 Feb 11, 2014 Feb 10, 2014
SC 13G SC 13G 0001193125-14-043115 Feb 10, 2014
S-8 FORM S-8 0001193125-14-039255 Feb 7, 2014
SC 13G AGIOS PHARMACEUTICALS 0001072613-14-000051 Feb 6, 2014
4 FORM 4 SUBMISSION 0001209191-14-007366 Feb 4, 2014 Feb 3, 2014
4 FORM 4 SUBMISSION 0001209191-14-007368 Feb 4, 2014 Feb 3, 2014
4 FORM 4 SUBMISSION 0001209191-14-005331 Jan 28, 2014 Jan 27, 2014
4 FORM 4 SUBMISSION 0001209191-14-004638 Jan 23, 2014 Jan 21, 2014
4 FORM 4 SUBMISSION 0001209191-14-004642 Jan 23, 2014 Jan 21, 2014
4 FORM 4 SUBMISSION 0001209191-14-004379 Jan 22, 2014 Jan 21, 2014
8-K FORM 8-K 0001193125-14-008746 Jan 13, 2014
8-K FORM 8-K 0001193125-13-469695 Dec 11, 2013 Dec 10, 2013
8-K FORM 8-K 0001193125-13-468313 Dec 10, 2013 Dec 4, 2013
4 FORM 4 SUBMISSION 0001209191-13-055678 Dec 6, 2013 Dec 4, 2013
4 FORM 4 SUBMISSION 0001209191-13-055673 Dec 6, 2013 Dec 4, 2013
4 FORM 4 SUBMISSION 0001209191-13-055683 Dec 6, 2013 Dec 4, 2013
SC 13G 0000315066-13-004679 Nov 12, 2013
8-K FORM 8-K 0001193125-13-431643 Nov 7, 2013
10-Q FORM 10-Q 0001193125-13-433119 Nov 7, 2013 Sep 30, 2013
3 FORM 3 SUBMISSION 0001209191-13-045773 Sep 26, 2013 Sep 24, 2013
8-K FORM 8-K 0001193125-13-379121 Sep 26, 2013 Sep 24, 2013
4 FORM 4 SUBMISSION 0001209191-13-045775 Sep 26, 2013 Sep 24, 2013
10-Q FORM 10-Q 0001193125-13-358412 Sep 5, 2013 Jun 30, 2013
4 FORM 4 SUBMISSION 0001209191-13-043274 Sep 5, 2013 Aug 28, 2013
8-K FORM 8-K 0001193125-13-357078 Sep 4, 2013 Aug 28, 2013
SC 13D SC 13D 0001193125-13-321700 Aug 6, 2013
4 FORM 4 SUBMISSION 0001209191-13-038506 Jul 31, 2013 Jul 29, 2013